Testing Two New Glucose Monitors in Adults With Diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests two new continuous glucose monitoring (CGM) systems—devices that track blood sugar levels throughout the day—to make sure they work accurately and safely. You'll wear both sensors for 17 days while visiting the clinic six times so researchers can compare the readings to blood tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Have type 1 or type 2 diabetes diagnosed at least 6 months ago
- Be 18 years or older
- Have normal blood pressure, heart rate, and temperature at screening
- Allow the study team to place sensors on your upper arm and draw blood samples from your arm vein
- Commit to wearing two sensors at once for 17 days and attending six clinic visits
- If you have type 1 diabetes, you must have used a continuous glucose monitor before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Hear when a new Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.